Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

Por Fox, Robert J., Coffey, Christopher S., Conwit, Robin, Cudkowicz, Merit E., Gleason, Trevis, Goodman, Andrew, Klawiter, Eric C., Matsuda, Kazuko, McGovern, Michelle, Naismith, Robert T., Ashokkumar, Akshata, Barnes, Janel, Ecklund, Dixie, Klingner, Elizabeth, Koepp, Maxine, Long, Jeffrey D., Natarajan, Sneha, Thornell, Brenda, Yankey, Jon, Bermel, Robert A., Debbins, Josef P., Huang, Xuemei, Jagodnik, Patricia, Lowe, Mark J., Nakamura, Kunio, Narayanan, Sridar, Sakaie, Ken E., Thoomukuntla, Bhaskar, Zhou, Xiaopeng, Krieger, Stephen, Alvarez, Enrique, Apperson, Michelle, Bashir, Khurram, Cohen, Bruce A., Coyle, Patricia K., Delgado, Silvia, Dewitt, L. Dana, Flores, Angela, Giesser, Barbara S., Goldman, Myla D., Jubelt, Burk, Lava, Neil, Lynch, Sharon G., Moses, Harold, Ontaneda, Daniel, Perumal, Jai S., Racke, Michael, Repovic, Pavle, Riley, Claire S., Severson, Christopher, Shinnar, Shlomo, Suski, Valerie, Weinstock-Guttman, Bianca, Yadav, Vijayshree, Zabeti, Aram
Publicado no N Engl J Med (2018)